Statement
26 Sep 2024
Statement from IFPMA at UN HLM on AMR 2024
On 26 September 2024, IFPMA submitted the following statement from the floor at the UN High-Level Meeting on AMR. Eight years after the first ever AMR high-level meeting we find ourselves at the precipice of turning the tide. The pharmaceutical industry heard the call to action at the first high-level meeting, and through establishing the...
Read more
Statement
16 Sep 2024
Innovative pharmaceutical industry leaders reinforce ethics and business integrity in APEC economies and health sectors
IFPMA, with support and representation from industry leaders, joins stakeholders this week at the 11th Business Ethics for APEC SMEs Forum. This Forum – and the initiative on which it is based – supports the advancement of ethical business practices in the Asia-Pacific economies, with a focus on the health sector and wider health ecosystem....
Read more
External study
12 Sep 2024
The value of prevention for economic growth and the sustainability of healthcare, social care and welfare systems (The European House – Ambrosetti)
Read more